Earnings Results: Novavax stock drops as wider-than-expected loss overshadows vaccine booster data
Novavax Inc. shares fell in the extended session Thursday after the biotechs wider-than-expected loss on the quarter overshadowed positive results for its COVID-19 vaccine booster. Novavax
NVAX,
+5.54%
shares fell 9% after hours, following a 5.5% gain…
